Key Insights from Crohn’s & Colitis Congress® 2025: Revolutionary Research, Pregnancy Considerations, AI Innovations, and More (Crohn’s & Colitis Congress)

The Crohn’s & Colitis Congress 2025 unveiled groundbreaking advancements in IBD care, from AI-driven disease monitoring and non-invasive sweat-based diagnostics to evolving guidelines on pregnancy and obesity management. Experts emphasized the importance of medication adherence during pregnancy, the potential of GLP-1 drugs in IBD treatment, and the role of bariatric surgery in disease outcomes. Meanwhile, AI innovations like IBD Aware and Smart Notes are set to transform patient monitoring and clinical workflows. With these cutting-edge developments, the future of IBD care is shifting rapidly—but the real question remains: Are we ready to embrace this revolution in precision medicine?